ATE461205T1 - Verwendung von bestimmten lösungsmitteln zur herstellung von bisphosphonsäuren - Google Patents

Verwendung von bestimmten lösungsmitteln zur herstellung von bisphosphonsäuren

Info

Publication number: ATE461205T1
Authority: AT; Austria
Prior art keywords: bisphosphonic acids; certain solvents; acid; diluent; aromatic hydrocarbon
Prior art date: 2002-05-17

Application number

AT03729005T

Other languages

English (en)

Inventor

Rami Lidor-Hadas

Zvi Harel

Revital Lifshitz-Liron

Eti Kovalevski-Liron

Original Assignee

Teva Pharma

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

2002-05-17

Filing date

2003-05-19

Publication date

2010-04-15

2003-05-19 Application filed by Teva Pharma filed Critical Teva Pharma

2010-04-15 Application granted granted Critical

2010-04-15 Publication of ATE461205T1 publication Critical patent/ATE461205T1/de

Links

239000002253 acid Substances 0.000 title abstract 2
150000007513 acids Chemical class 0.000 title abstract 2
239000002904 solvent Substances 0.000 title 1
NBIIXXVUZAFLBC-UHFFFAOYSA-N Phosphoric acid Chemical compound OP(O)(O)=O NBIIXXVUZAFLBC-UHFFFAOYSA-N 0.000 abstract 2
125000002029 aromatic hydrocarbon group Chemical group 0.000 abstract 2
239000003085 diluting agent Substances 0.000 abstract 2
IIDJRNMFWXDHID-UHFFFAOYSA-N Risedronic acid Chemical compound OP(=O)(O)C(P(O)(O)=O)(O)CC1=CC=CN=C1 IIDJRNMFWXDHID-UHFFFAOYSA-N 0.000 abstract 1
150000001735 carboxylic acids Chemical class 0.000 abstract 1
150000001875 compounds Chemical class 0.000 abstract 1
239000012530 fluid Substances 0.000 abstract 1
238000004519 manufacturing process Methods 0.000 abstract 1
235000011007 phosphoric acid Nutrition 0.000 abstract 1
229920001296 polysiloxane Polymers 0.000 abstract 1
-1 risedronic acid Chemical class 0.000 abstract 1
229960000759 risedronic acid Drugs 0.000 abstract 1
ISIJQEHRDSCQIU-UHFFFAOYSA-N tert-butyl 2,7-diazaspiro[4.5]decane-7-carboxylate Chemical compound C1N(C(=O)OC(C)(C)C)CCCC11CNCC1 ISIJQEHRDSCQIU-UHFFFAOYSA-N 0.000 abstract 1

Classifications

- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
- C07F9/00—Compounds containing elements of Groups 5 or 15 of the Periodic Table
- C07F9/02—Phosphorus compounds
- C07F9/28—Phosphorus compounds with one or more P—C bonds
- C07F9/38—Phosphonic acids [RP(=O)(OH)2]; Thiophosphonic acids ; [RP(=X1)(X2H)2(X1, X2 are each independently O, S or Se)]
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
- C07F9/00—Compounds containing elements of Groups 5 or 15 of the Periodic Table
- C07F9/02—Phosphorus compounds
- C07F9/28—Phosphorus compounds with one or more P—C bonds
- C07F9/38—Phosphonic acids [RP(=O)(OH)2]; Thiophosphonic acids ; [RP(=X1)(X2H)2(X1, X2 are each independently O, S or Se)]
- C07F9/3804—Phosphonic acids [RP(=O)(OH)2]; Thiophosphonic acids ; [RP(=X1)(X2H)2(X1, X2 are each independently O, S or Se)] not used, see subgroups
- C07F9/3839—Polyphosphonic acids
- C07F9/3873—Polyphosphonic acids containing nitrogen substituent, e.g. N.....H or N-hydrocarbon group which can be substituted by halogen or nitro(so), N.....O, N.....S, N.....C(=X)- (X =O, S), N.....N, N...C(=X)...N (X =O, S)
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
- C07F9/00—Compounds containing elements of Groups 5 or 15 of the Periodic Table
- C07F9/02—Phosphorus compounds
- C07F9/547—Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom
- C07F9/553—Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom having one nitrogen atom as the only ring hetero atom
- C07F9/576—Six-membered rings
- C07F9/58—Pyridine rings
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
- C07F9/00—Compounds containing elements of Groups 5 or 15 of the Periodic Table
- C07F9/02—Phosphorus compounds
- C07F9/547—Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom
- C07F9/645—Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom having two nitrogen atoms as the only ring hetero atoms
- C07F9/6503—Five-membered rings
- C07F9/6506—Five-membered rings having the nitrogen atoms in positions 1 and 3
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
- C07F9/00—Compounds containing elements of Groups 5 or 15 of the Periodic Table
- C07F9/02—Phosphorus compounds
- C07F9/547—Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom
- C07F9/6561—Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom containing systems of two or more relevant hetero rings condensed among themselves or condensed with a common carbocyclic ring or ring system, with or without other non-condensed hetero rings

Landscapes

Chemical & Material Sciences (AREA)
Organic Chemistry (AREA)
Health & Medical Sciences (AREA)
Life Sciences & Earth Sciences (AREA)
Biochemistry (AREA)
General Health & Medical Sciences (AREA)
Molecular Biology (AREA)
Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)

AT03729005T 2002-05-17 2003-05-19 Verwendung von bestimmten lösungsmitteln zur herstellung von bisphosphonsäuren ATE461205T1 (de)

Applications Claiming Priority (6)

Application Number	Priority Date	Filing Date	Title
US38128402P	2002-05-17	2002-05-17
US40131302P	2002-08-06	2002-08-06
US42333702P	2002-11-01	2002-11-01
US43183802P	2002-12-09	2002-12-09
US45019303P	2003-02-25	2003-02-25
PCT/US2003/015676 WO2003097655A1 (en)	2002-05-17	2003-05-19	Use of certain diluents for making bisphosphonic acids

Publications (1)

Publication Number	Publication Date
ATE461205T1 true ATE461205T1 (de)	2010-04-15

Family

ID=29554537

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
AT03729005T ATE461205T1 (de)	2002-05-17	2003-05-19	Verwendung von bestimmten lösungsmitteln zur herstellung von bisphosphonsäuren

Country Status (12)

Country	Link
US (3)	US7038083B2 (de)
EP (1)	EP1476451B1 (de)
JP (1)	JP3857706B2 (de)
KR (1)	KR100681282B1 (de)
CN (1)	CN1665825A (de)
AT (1)	ATE461205T1 (de)
AU (1)	AU2003233569A1 (de)
CA (2)	CA2485443C (de)
DE (1)	DE60331724D1 (de)
IL (1)	IL165227A0 (de)
PL (1)	PL373574A1 (de)
WO (1)	WO2003097655A1 (de)

Families Citing this family (43)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
NZ552514A (en) *	2001-12-24	2008-08-29	Teva Pharma	Dosage form with a core tablet of active ingredient sheathed in a compressed annular body of powder or granular material, and process and tooling for producing it
US20040052843A1 (en) *	2001-12-24	2004-03-18	Lerner E. Itzhak	Controlled release dosage forms
AU2003233569A1 (en) *	2002-05-17	2003-12-02	Teva Pharmaceutical Industries Ltd.	Use of certain diluents for making bisphosphonic acids
ATE451380T1 (de) *	2003-08-21	2009-12-15	Sun Pharmaceuticals Ind Ltd	Verfahren zur herstellung von bisphosphonsäureverbindungen
EP2206717B1 (de) *	2003-12-23	2013-03-27	Alchymars S.p.A.	Prozess zur Herstellung von Alkyl- und Aryl diphosphonsäuren und deren Salzen
WO2005063717A1 (en) *	2003-12-26	2005-07-14	Natco Pharma Limited	An improved process for the preparation of zoledronic acid
WO2006002348A2 (en) *	2004-06-23	2006-01-05	Teva Pharmaceutical Industies Ltd.	Solid and crystalline ibandronic acid
US7687482B2 (en)	2006-03-17	2010-03-30	The Board Of Trustees Of The University Of Illinois	Bisphosphonate compounds and methods
US8012949B2 (en)	2004-10-08	2011-09-06	The Board Of Trustees Of The University Of Illinois	Bisphosphonate compounds and methods with enhanced potency for multiple targets including FPPS, GGPPS, and DPPS
EP1802641B8 (de)	2004-10-08	2012-03-07	The Board Of Trustees Of The University Of Illinois	Bisphosphonatverbindungen und -verfahren für knochenschwundkrankheiten, krebs, knochenschmerzen, immunstörungen und infektionskrankheiten
US7214818B2 (en)	2004-10-29	2007-05-08	Hoffmann-La Roche Inc.	Method for synthesizing bisphosphonate
PL199215B1 (pl) *	2004-12-28	2008-08-29	Politechnika Gdanska	Sposób wytwarzania kwasu [1-hydroksy-2-(3-pirydylo)etylidenobisfosfonowego] oraz jego soli monosodowej dwu i pół wodnej
US7872144B2 (en) *	2005-06-13	2011-01-18	Jubilant Organosys Limited	Process for producing biphosphonic acids and forms thereof
US8003820B2 (en) *	2005-10-20	2011-08-23	Dr. Reddy's Laboratories Limited	Process for preparing bisphosphonic acids
WO2007069049A2 (en) *	2005-12-16	2007-06-21	Wockhardt Ltd	Processes for the preparation of pure zoledronic acid
WO2007083240A2 (en)	2006-01-20	2007-07-26	Aurobindo Pharma Limited	An improved process for the preparation of bisphosphonic acids
CN101421284A (zh) *	2006-04-25	2009-04-29	特瓦制药工业有限公司	伊班膦酸的结晶形式和其制备方法
WO2007125521A2 (en) *	2006-05-02	2007-11-08	Ranbaxy Laboratories Limited	Polymorphic form of zoledronic acid and processes for their preparation
JP5354858B2 (ja) *	2006-05-09	2013-11-27	株式会社Ａｄｅｋａ	スルホンアミド化合物の金属塩を含有するポリエステル樹脂組成物
JP2009536639A (ja) *	2006-05-11	2009-10-15	アイエヌディー−スイフトラボラトリーズリミテッド	純リセドロン酸または塩を調製するための方法
WO2008044245A2 (en) *	2006-10-10	2008-04-17	Matrix Laboratories Ltd	A process for the preparation of risedronate sodium hemipentahydrate
CA2570949A1 (en) *	2006-12-12	2008-06-12	Apotex Pharmachem Inc.	Ibandronate sodium propylene glycol solvate and processes for the preparation thereof
CN101679465B (zh) *	2007-04-11	2013-08-21	霍夫曼-拉罗奇有限公司	伊班膦酸盐的制备方法
US7605148B2 (en) *	2007-04-16	2009-10-20	Aurobindo Pharma Ltd.	Aqueous oral solution of bisphosphonic acid
WO2008152518A2 (en) *	2007-05-16	2008-12-18	Actavis Group Ptc Ehf	Process for the preparation of risedronic acid or risedronate sodium
WO2009050731A2 (en) *	2007-06-20	2009-04-23	Alkem Laboratories Ltd	Novel process for preparing risedronic acid
KR100877667B1 (ko)	2007-06-28	2009-01-08	보령제약 주식회사	리세드로네이트의 제조 방법
WO2009034580A1 (en) *	2007-09-11	2009-03-19	Fleming Laboratories Limited	Improved process for the preparation of risedronate sodium hemipentahydrate
JP5258370B2 (ja) *	2008-05-08	2013-08-07	ダイト株式会社	リセドロン酸の工業的製造方法
WO2010003704A2 (en) *	2008-07-11	2010-01-14	Synthon B.V.	Process for making 1-hydroxyalkylidene-1,1-biphosphonic acids
PL213599B1 (pl) *	2008-10-31	2013-03-29	Politechnika Gdanska	Sposób otrzymywania kwasu [1-hydroksy-2-(1H-imidazol-1-ilo)-etylideno] bisfosfonowego
US20100130746A1 (en) *	2008-11-26	2010-05-27	Martin Kas	Process for Making Zoledronic Acid
WO2010060619A1 (en) *	2008-11-26	2010-06-03	Synthon B.V.	Process for making zoledronic acid
EP2192126B1 (de)	2008-11-26	2013-03-27	Synthon B.V.	Verfahren zur Herstellung von Zoledronsäure
US20160016982A1 (en)	2009-07-31	2016-01-21	Thar Pharmaceuticals, Inc.	Crystallization method and bioavailability
US9169279B2 (en)	2009-07-31	2015-10-27	Thar Pharmaceuticals, Inc.	Crystallization method and bioavailability
DK2459176T3 (en)	2009-07-31	2017-12-04	Gruenenthal Gmbh	Crystallization process and bioavailability
WO2011016738A1 (en)	2009-08-05	2011-02-10	Zaklady Farmaceutyczne Polpharma Sa	A process for the synthesis of 1-hydroxy-3-(n-methylpentylamino) propylidene bisphosphonic acid monosodium salt, monohydrate
WO2011023280A1 (en)	2009-08-28	2011-03-03	Synthon B.V.	Process for making 1-hydroxyalkylidene-1,1-biphosphonic acids
US8882740B2 (en) *	2009-12-23	2014-11-11	Stryker Trauma Gmbh	Method of delivering a biphosphonate and/or strontium ranelate below the surface of a bone
US9340565B2 (en)	2010-11-24	2016-05-17	Thar Pharmaceuticals, Inc.	Crystalline forms
US10195218B2 (en)	2016-05-31	2019-02-05	Grunenthal Gmbh	Crystallization method and bioavailability
EP3553067A1 (de) *	2018-04-10	2019-10-16	Abiogen Pharma S.p.A.	Polymorph von natriumneridronat und herstellungsverfahren dafür

Family Cites Families (33)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
DE3016289A1 (de) *	1980-04-28	1981-10-29	Henkel KGaA, 4000 Düsseldorf	Verfahren zur herstellung von omega -amino-1-hydroxyalkyliden-1,1-bis-phosphonsaeuren
IT1201087B (it) *	1982-04-15	1989-01-27	Gentili Ist Spa	Bifosfonati farmacologicamente attivi,procedimento per la loro preparazione e relative composizioni farmaceutiche
IT1196315B (it) *	1984-10-29	1988-11-16	Gentili Ist Spa	Procedimento per la preparazione di acidi difosfonici
DE3623397A1 (de) *	1986-07-11	1988-01-14	Boehringer Mannheim Gmbh	Neue diphosphonsaeurederivate, verfahren zu deren herstellung und diese verbindungen enthaltende arzneimittel
DE3700772A1 (de)	1987-01-13	1988-07-21	Inst Khim Kinetiki I Gorenija	Verfahren zur herstellung von i-funktionellsubstituierten alkyliden-i,i-diphosphonsaeuren und deren gemischen
US4922007A (en)	1989-06-09	1990-05-01	Merck & Co., Inc.	Process for preparing 4-amino-1-hydroxybutylidene-1,1-bisphosphonic acid or salts thereof
US5019651A (en)	1990-06-20	1991-05-28	Merck & Co., Inc.	Process for preparing 4-amino-1-hydroxybutylidene-1,1-bisphosphonic acid (ABP) or salts thereof
US5159108A (en) *	1990-09-18	1992-10-27	Merck & Co., Inc.	Process for preparing an antihypercalcemic agent
US5039819A (en) *	1990-09-18	1991-08-13	Merck & Co., Inc.	Diphosphonate intermediate for preparing an antihypercalcemic agent
US5327490A (en) *	1991-02-19	1994-07-05	Intervoice, Inc.	System and method for controlling call placement rate for telephone communication systems
US5358941A (en) *	1992-12-02	1994-10-25	Merck & Co., Inc.	Dry mix formulation for bisphosphonic acids with lactose
TW257765B (de) *	1993-08-25	1995-09-21	Merck & Co Inc
US5510517A (en) *	1993-08-25	1996-04-23	Merck & Co., Inc.	Process for producing N-amino-1-hydroxy-alkylidene-1,1-bisphosphonic acids
US5449819A (en) *	1994-06-06	1995-09-12	Merck & Co., Inc.	Process for removing waste pox, alendronate and its by products
US5589691A (en) *	1994-06-06	1996-12-31	Merck & Co., Inc.	Process for recovery and recycle of methanesulfonic acid and phosphorous acid
JP3349032B2 (ja) *	1996-03-15	2002-11-20	株式会社東芝	発呼制御方法
KR100192215B1 (ko)	1996-09-03	1999-06-15	강재헌	3-아미노-1-히드록시프로판-1,1-디포스폰산의 제조방법
CA2197267C (en)	1997-02-11	2000-02-08	Yong Tao	Process for the production of 4-amino-1-hydroxybutylidene-1,1-bisphosphonic acid or salts thereof
ES2153794B1 (es) *	1999-08-06	2001-10-16	Medichem Sa	Procedimiento para la obtencion del acido 4-amino-1-hidroxibutiliden-1,1-bisfosfonico y de su sal monosodica trihidratada.
US6562974B2 (en)	2000-02-01	2003-05-13	The Procter & Gamble Company	Process for making geminal bisphosphonates
TR200101250A2 (tr) *	2001-05-10	2003-04-21	E�S Eczaciba�I �Zg�N K�Myasal �R�Nler Sanay� A.�.	4-amino-1-hidroksibutiliden-1,1-bifosfonik asit veya tuzlarının hazırlanmasına ilişkin proses
GB0115824D0 (en) *	2001-06-28	2001-08-22	Rhodia Cons Spec Ltd	Improved solvent systems
US6645974B2 (en) *	2001-07-31	2003-11-11	Merck & Co., Inc.	Androgen receptor modulators and methods for use thereof
ITMI20020908A1 (it) *	2002-04-29	2003-10-29	Chemi Spa	Processo di preparazione di sodio alendronato
AU2003233569A1 (en) *	2002-05-17	2003-12-02	Teva Pharmaceutical Industries Ltd.	Use of certain diluents for making bisphosphonic acids
HUP0300227A2 (hu) *	2003-01-28	2004-09-28	Richter Gedeon Vegyészeti Gyár Rt.	Eljárás nagy tisztaságú 2-szubsztituált -1-(hidroxi-etilidén)-1,1-biszfoszfonsavak és sóik előállítására
ATE451380T1 (de) *	2003-08-21	2009-12-15	Sun Pharmaceuticals Ind Ltd	Verfahren zur herstellung von bisphosphonsäureverbindungen
EP2206717B1 (de) *	2003-12-23	2013-03-27	Alchymars S.p.A.	Prozess zur Herstellung von Alkyl- und Aryl diphosphonsäuren und deren Salzen
US7361761B2 (en) *	2004-09-28	2008-04-22	Orchid Chemicals & Pharmaceuticals Ltd.	Process for the preparation of bisphosphonic acid
US8003820B2 (en) *	2005-10-20	2011-08-23	Dr. Reddy's Laboratories Limited	Process for preparing bisphosphonic acids
EP1803727B1 (de) *	2005-12-27	2009-03-11	IPCA Laboratories Limited	Verbesserter Herstellungsprozess von 4-Amino-Hydroxybutyliden-1,1-bisphosphonischer Säure und ihrer Salze
WO2007083240A2 (en) *	2006-01-20	2007-07-26	Aurobindo Pharma Limited	An improved process for the preparation of bisphosphonic acids
WO2007096896A1 (en) *	2006-02-20	2007-08-30	Alembic Limited	An improved process for the preparation of biphosphonic derivatives

2003
- 2003-05-19 AU AU2003233569A patent/AU2003233569A1/en not_active Abandoned
- 2003-05-19 EP EP03729005A patent/EP1476451B1/de not_active Expired - Lifetime
- 2003-05-19 AT AT03729005T patent/ATE461205T1/de not_active IP Right Cessation
- 2003-05-19 JP JP2004505386A patent/JP3857706B2/ja not_active Expired - Lifetime
- 2003-05-19 PL PL03373574A patent/PL373574A1/xx not_active Application Discontinuation
- 2003-05-19 CN CN038160226A patent/CN1665825A/zh active Pending
- 2003-05-19 CA CA2485443A patent/CA2485443C/en not_active Expired - Fee Related
- 2003-05-19 WO PCT/US2003/015676 patent/WO2003097655A1/en not_active Ceased
- 2003-05-19 KR KR1020047018564A patent/KR100681282B1/ko not_active Expired - Fee Related
- 2003-05-19 US US10/442,001 patent/US7038083B2/en not_active Expired - Fee Related
- 2003-05-19 IL IL16522703A patent/IL165227A0/xx unknown
- 2003-05-19 CA CA002657002A patent/CA2657002A1/en not_active Abandoned
- 2003-05-19 DE DE60331724T patent/DE60331724D1/de not_active Expired - Fee Related
2006
- 2006-02-08 US US11/350,462 patent/US20060128960A1/en not_active Abandoned
2009
- 2009-02-10 US US12/368,805 patent/US20090209763A1/en not_active Abandoned

Also Published As

Publication number	Publication date
AU2003233569A1 (en)	2003-12-02
US20090209763A1 (en)	2009-08-20
JP2005526140A (ja)	2005-09-02
JP3857706B2 (ja)	2006-12-13
DE60331724D1 (de)	2010-04-29
CN1665825A (zh)	2005-09-07
US20040043967A1 (en)	2004-03-04
KR100681282B1 (ko)	2007-02-12
CA2485443C (en)	2010-04-06
KR20040111633A (ko)	2004-12-31
US20060128960A1 (en)	2006-06-15
CA2485443A1 (en)	2003-11-27
EP1476451A1 (de)	2004-11-17
WO2003097655A1 (en)	2003-11-27
IL165227A0 (en)	2005-12-18
PL373574A1 (en)	2005-09-05
CA2657002A1 (en)	2003-11-27
US7038083B2 (en)	2006-05-02
EP1476451B1 (de)	2010-03-17

Legal Events

Date	Code	Title	Description
2010-09-15	RER	Ceased as to paragraph 5 lit. 3 law introducing patent treaties

Publication	Publication Date	Title
DE60331724D1 (de)	2010-04-29	Verwendung von bestimmten lösungsmitteln zur herstellung von bisphosphonsäuren
ATE451380T1 (de)	2009-12-15	Verfahren zur herstellung von bisphosphonsäureverbindungen
ATE318926T1 (de)	2006-03-15	Verfahren zur herstellung von cadaverindicarboxylat und dessen verwendung zur herstellung von nylon
ATE392430T1 (de)	2008-05-15	Verfahren zur herstellung von dipeptiden
ATE334220T1 (de)	2006-08-15	Verfahren zur herstellung von l-aminosäuren unter verwendung von stämmen der familie enterobacteriaceae
ATE496995T1 (de)	2011-02-15	Verfahren zur herstellung mikrobieller transglutaminase
ATE310718T1 (de)	2005-12-15	Verfahren zur herstellung von (meth)acrylsäureanhydrid
ATE444949T1 (de)	2009-10-15	Verfahren zur herstellung von n-monoalkyl-beta- aminoalkoholen
DE60314730D1 (de)	2007-08-16	Verwendung von 4-aminopyrimidinen zur antimikrobiellen behandlung von oberflächen
ATE270275T1 (de)	2004-07-15	Verfahren zur herstellung von 2-aryl-3-aryl-5- halogen-pyridinen, verwendbar als cox-2 inhibitoren
DE60300861D1 (de)	2005-07-21	Verfahren zur herstellung von siliconverbindungen
ATE301696T1 (de)	2005-08-15	Verfahren zum kleben von substraten unter verwendung einer lichtaktivierbaren klebstofffolie
ATE261981T1 (de)	2004-04-15	Verfahren zur herstellung von alkylphosphonsäuren
DE60124289D1 (de)	2006-12-14	Verfahren zur herstellung von 21-hydroxy-6,19-oxidoprogesteron (21oh-6op)
DE50200809D1 (de)	2004-09-16	Verfahren zur herstellung von n-phosphonomethyliminodiessigsäure
DE60211695D1 (de)	2006-06-29	Verfahren zur herstellung von phosphorsäureestern
ATE356110T1 (de)	2007-03-15	Verfahren zur herstellung von kristallinem cholinascorbat
DE60235820D1 (de)	2010-05-12	Verfahren zur herstellung von azoverbindungen
ATE389010T1 (de)	2008-03-15	Verfahren zur herstellung von optisch aktiven pyridinethanol-derivaten
DE50300920D1 (de)	2005-09-08	Ferrocenylliganden und ein verfahren zur herstellung solcher liganden
ATE428116T1 (de)	2009-04-15	Verfahren zur identifizierung wahrend der apoptose modifizierter proteine
DE50109809D1 (de)	2006-06-22	Verfahren zur Herstellung von D- oder L-Menthol
ATE440102T1 (de)	2009-09-15	Verfahren zur herstellung von monohydro- perfluoralkanen, bis(perfluoralkyl)phosphinaten und perfluoralkylphosphonaten
DE50201297D1 (de)	2004-11-18	Verfahren zur herstellung von 1-hydroxy-1, 1-diphosphonsäureverbindungen
DE60118247D1 (de)	2006-05-11	Magnetfeldofen und betriebsverfahren zur herstellung von bandförmigen dendritischen kristallen